Clicky

XOMA Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock(XOMAP) News

Date Title
Jun 21 Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
Feb 28 XOMA to Present at Upcoming Investor Conferences in March
Jan 11 FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
Jan 2 XOMA Announces Stock Repurchase Program of up to $50 Million
Dec 20 XOMA Declares Quarterly Preferred Stock Dividends
Dec 19 XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties